Showing 25 of 858 items meeting your criteria.
| | Type | Category | Supplier | |
|---|
| |
 | Krishgen Biosystems provide sensitive, validated ELISA kits as a solution for your cytokine testing. |
Documents | ELISA | Krishgen Biosystems | |
 | Krishgen offers a range of ELISAs to quantify bispecific antibody drug levels accurately and quickly in serum and plasma samples. |
Documents | ELISA | Krishgen Biosystems | |
 | Discover iXCells collection of primary vascular cells sourced from both human and animal tissues, accompanied by supporting media. Our range includes cells from cardiac, cardiac microvascular, umbilical vein, dermal, and other vascular origins. |
Documents | Primary Cells | iXCells Biotechnologies | |
 | iXCells streamlined custom iPSC generation services liberate you from the demanding and labour-intensive task of cell reprogramming and gene editing, allowing you to focus on research. |
Documents | Service | iXCells Biotechnologies | |
 | iXCells renal cell models offer accurate and reliable insights, enabling researchers to study kidney function, disease mechanisms, and potential therapeutic interventions. |
Documents | Primary Cells | iXCells Biotechnologies | |
 | iXCells offers custom cell isolation services for a variety of cell types obtained from ethically procured donor tissues according to your specific criteria. |
Documents | Primary Cells | iXCells Biotechnologies | |
 | Accelerating neurological research, drug screening, and disease modelling with a wide range of Human iPSC-Derived Cells – supported by research publications and trusted by researchers, scientists, academia, and global organizations.
Primary Cell Products designed to empower researchers with innovative solutions that accelerate drug discovery workflows, with a focus on neurodegenerative and central nervous system diseases. |
Documents | Neuroscience | iXCells Biotechnologies | |
 | ProSci has developed SARS-CoV-2 pseudoviruses with a luciferase reporter allowing researchers to quickly build their own neutralization and inhibitor interaction assays. These pseudoviruses have been engineered to lack the appropriate coding for the virus to replicate. |
Documents | COVID-19 | ProSci | |
 | Single domain antibodies (sdAbs) are small antigen-binding fragments with unique characteristics that make them useful alternatives to conventional antibodies and important tools in research, diagnostics and therapeutics. |
Documents | Antibodies | ProSci | |
 | The SARS-CoV-2 virus which causes COVID-19 is comprised of 10 open reading frames (ORFs). Many of these create structural proteins and nonstructural proteins, but several of them generate unique proteins named after the ORF they are encoded by. Inhibiting some of these SARS-CoV-2 proteins which contribute to viral immune evasion could lead to faster clearing of SARS-CoV-2 infection by improving the hosts antiviral systems. ProScis catalogue has antibodies and recombinant proteins to many of the SARS-CoV-2 ORF accessory proteins. |
Documents | COVID-19 | ProSci | |
 | LeadGene specialises in the design and development of high-quality antibodies & proteins. View their product catalogue here. |
Documents | Catalogue | LeadGene Biomedical | |
 | Cytokines for cell therapy diagram flyer |
Documents | Cytokines | LeadGene Biomedical | |
 | XenoForm Tumour Gel is made from synthetic biological materials, which can provide an extracellular matrix microenvironment without the risk of zoonotic pathogens or toxins. It has high activity, stability, biocompatibility, and safety, and can be operated at room temperature. It is also easy to inject and allows self-adjustment of gel density. This product can be used in tumour growth experiments with various mouse cancer models. |
Documents | Cancer | LeadGene Biomedical | |
 | The 3D cell culture hydrogel system simulates the microenvironment of human tissue using synthetic biological materials. It is stable, adjustable, easy to operate, and has high biological compatibility, which can be applied in 3D cell culture, tumour formation experiments, tumour angiogenesis and invasion study. |
Documents | Cell Culture | LeadGene Biomedical | |
 | CHP Applications - Fibrotic Conditions |
Documents | Peptides | 3Helix | |
 | CHP Applications - Skeletal Disease and Development |
Documents | Peptides | 3Helix | |
 | There has been significant interest in the role of programmed cell death protein 1 (PD-1) and its ligand programmed death-ligand 1 (PD-L1) in modulating immune responses. The emergence of PD-1-targeted therapies has revolutionized cancer treatment, leading to a better understanding of immune checkpoint mechanisms and their uses in various research fields. This paper offers a review of significant publications on the use of PD-1 antibodies in cancer, immunology, and Alzheimers disease research. We will highlight the importance of PD-1 antibodies in resolving the complicated interactions between the immune system and pathological conditions as well as their potential to create novel therapeutic approaches. |
Documents | Antibodies | ProSci | |
 | Focus: Recombinant Antibodies |
Documents | Antibodies | AdipoGen Life Sciences | |
 | Chemodex is an expert in the synthesis of fluorescent substances derived from fluorophores such as coumarin, fluorescein, rhodamine and pyrene. |
Documents | Biochemicals | Chemodex | |
 | Focusing on Emerging Research Fields: Metabolic Syndrome Biomarkers, Inflammatory Diseases Biomarkers, Cancer & Autoimmune Diseases Biomarkers, SARS-CoV-2/COVID-19 Research Assays |
Documents | ELISA | AdipoGen Life Sciences | |
 | Coronaviruses (CoVs) – SARS-CoV & SARS-CoV-2 [2019-nCoV] research |
Documents | COVID-19 | AdipoGen Life Sciences | |
 | Progranulin (PGRN) is a highly conserved secreted cysteine-rich protein that is expressed in multiple cell types, both in the CNS and in peripheral tissues. |
Documents | Neuroscience | AdipoGen Life Sciences | |
 | Focus: Emerging Fields in Neuroinflammation & Neurological Diseases |
Documents | Neuroscience | AdipoGen Life Sciences | |
 | AdipoGen Life Sciences specialises in developing recombinant proteins that show enhanced activity and long half-life, produced in mammalian cells. Using proprietary in-house technologies together with established and published technologies, they engineer, develop and produce an innovative panel of recombinant proteins for different research fields including Cell Therapy Research. |
Documents | Recombinant Proteins | AdipoGen Life Sciences | |
 | Ligands & receptors |
Documents | Immunology | AdipoGen Life Sciences | |